{
  "id": 1783,
  "text": "The proportion of patients with an overall response in the cediranib group was $6 4 \\%$ compared with $45 \\%$ in the placebo group.Using the EORTC QLQ-C30, the authors reported a significantly worse quality of life associated with diarrhoea in the cediranib group $\\mathrm { ( p = 0 } .",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: The proportion of patients with an overall response in the cediranib group was $6 4 \\%$ compared with $45 \\%$ in the placebo group.Using the EORTC QLQ-C30, the authors reported a significantly worse quality of life associated with diarrhoea in the cediranib group $\\mathrm { ( p = 0 } .\n\n<question>: ",
  "ChatGPT_response_0": "在该研究中，接受西达利尼组患者的整体反应比例更高，达到64％，而安慰剂组为45％。使用EORTC QLQ-C30测量时，发现与腹泻相关的生活质量在西达利尼组中明显更差，这显示了腹泻对患者生活质量的负面影响。整体而言，这些结果表明西达利尼在治疗过程中可能会带来一些副作用，影响患者的整体反应率和生活质量。",
  "query": "在该研究中，哪一组患者的整体反应比例更高？使用EORTC QLQ-C30，哪一组与腹泻相关的生活质量更差？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在该研究中，哪一组患者的整体反应比例更高？使用EORTC QLQ-C30，哪一组与腹泻相关的生活质量更差？\n\n<reference text>: The proportion of patients with an overall response in the cediranib group was $6 4 \\%$ compared with $45 \\%$ in the placebo group.Using the EORTC QLQ-C30, the authors reported a significantly worse quality of life associated with diarrhoea in the cediranib group $\\mathrm { ( p = 0 } .\n\n<reply>: ",
  "response": "在该研究中，接受西达利尼组患者的整体反应比例更高，达到64％，而安慰剂组为45％。使用EORTC QLQ-C30测量时，发现与腹泻相关的生活质量在西达利尼组中明显更差，这显示了腹泻对患者生活质量的负面影响。整体而言，这些结果表明西达利尼在治疗过程中可能会带来一些副作用，影响患者的整体反应率和生活质量。"
}